ClinConnect ClinConnect Logo
Search / Trial NCT06277973

Feasibility Study of the Self-Care Immediate Stabilization Procedure (ISP) ® After a Traumatic Experience

Launched by TEL AVIV UNIVERSITY · Feb 18, 2024

Trial Information

Current as of August 22, 2025

Not yet recruiting

Keywords

Post Traumatic Stress Disorder (Ptsd) Emdr (Eye Movement Desensitization Reprocessing) Immediate Stabilization Procedure [Ips(r)] The 'Butterfly Hug' Acute Stress Disorder

ClinConnect Summary

This clinical trial is studying a program called the Immediate Stabilization Procedure (ISP®), which is designed to help people cope with the immediate effects of traumatic experiences, especially after events like the recent war in Israel. By using an online platform, the study aims to see if this intervention can help reduce the chances of developing long-term issues like Post-Traumatic Stress Disorder (PTSD).

To participate, you need to be at least 18 years old, speak Hebrew, and have been in Israel since October 7, 2023. You should have experienced some form of trauma during the war, such as hearing alarms or being in a dangerous situation. You will also need access to a computer or smartphone and basic skills to use the internet. If selected, you will take part in the intervention while being observed over a Zoom call, which will help researchers understand how well the program works. This study is still in the planning stages and is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Hebrew speakers
  • 2. Age 18 years or older
  • 3. Have been in Israel since October 7th 2023 (the start of the war)
  • 4. Were exposed to traumatic events during the war (Alarms, participated in battles, were attacked by terrorists, etcetera)
  • 5. Access to PC/smartphone
  • 6. Basic technological skills, ability to use the internet and email.
  • Exclusion Criteria:
  • 1. Diagnosed with psychotic conditions.
  • 2. Diagnosed with PTSD or complex PTSD.
  • 3. Diagnosed with alcohol use disorder or drug abuse disorder.
  • 4. Suicidal ideation
  • 5. Treated with medication, psychotherapy, or any other mental treatment
  • About 10 randomly selected subjects will perform the intervention while recorded via zoom in the presence of a research assistant. This will allow us to assess the way subjects utilize this intervention.

About Tel Aviv University

Tel Aviv University (TAU) is a leading research institution in Israel, renowned for its commitment to advancing knowledge and innovation across various fields, including medicine and biomedical research. With a strong emphasis on interdisciplinary collaboration, TAU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and developing novel therapeutic strategies. The university's robust network of researchers, state-of-the-art facilities, and partnerships with healthcare organizations enable it to contribute significantly to the global medical research community, fostering advancements that address critical health challenges.

Locations

Tel Aviv, , Israel

Patients applied

0 patients applied

Trial Officials

Oren Asman, LLD

Principal Investigator

Tel Aviv University

Yael Lahav, PhD

Principal Investigator

Tel Aviv University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported